The three chromosomal translocations t(11;18)(q21;q21), t(14;18)(q32;q21), and t(1;14)(p22;q32) are associated with MALT lymphoma. In a case of MALT lymphoma of the thyroid, we observed t(3;14)(p14.1;q32) by cytogenetic analysis. Fluorescence in situ hybridization studies showed that the immunoglobulin heavy chain locus (IGH) was rearranged on chromosome 14. Long-distance inverse polymerase chain reaction identified FOXP1 as the partner gene on chromosome 3. To determine the frequency of the t(3;14)(p14.1;q32), two fluorescence in situ hybridization assays were established to screen 91 MALT lymphomas, all of which were negative for the above-mentioned three translocations, and eight splenic and six nodal marginal zone lymphomas. Overall, nine MALT lymphomas (10%) harbored t(3;14)(p14.1;q32) comprising tumors of the thyroid (three of six), ocular adnexa (four of 20), and skin (two of 20), whereas those of the stomach (n ¼ 20), salivary gland (n ¼ 20), and lung (n ¼ 5) were negative as well as the splenic and nodal marginal zone lymphomas. Most t(3;14)(p14.1;q32) þ MALT lymphomas harbored additional genetic abnormalities, such as trisomy 3. Further studies revealed that the three known translocations and t(3;14)(p14.1;q32) are mutually exclusive. Real-time quantitative reverse transcriptase polymerase chain reaction showed upregulation of FOXP1 in cases with t(3;14)(p14.1;q32) or trisomy 3. This study identifies FOXP1 as a new translocation partner of IGH in a sitedependent subset of MALT lymphomas.
Introduction
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), first described by Isaacson and Wright, 1 and recently reviewed extensively by Isaacson and Du, 2 is recognized as a distinct clinicopathologic entity in the WHO classification of malignant lymphomas. 3 Histologically, MALT lymphomas are characterized by lymphoepithelial lesions and follicular colonization generated from proliferating neoplastic marginal zone-related cells. 4 MALT lymphoma most commonly occurs in the stomach but may affect every organ of the human body. 5 Interestingly, most MALT lymphomas arise at sites that would normally be devoid of organized lymphoid tissue. Chronic inflammation by persistent infections or autoimmune disorders may result in the development of organized lymphoid tissue in a first stage. [6] [7] [8] [9] [10] [11] This lymphoid tissue becomes genetically unstable with the acquisition of genetic aberrations leading to transformation into MALT lymphoma. Cytogenetic analysis has proved useful by demonstrating similar alterations in MALT lymphomas from different anatomic sites. The common translocations that characterize MALT lymphomas include t(11;18)(q21;q21), t(1;14)(p22;q32) and, more recently, t(14;18)(q32;q21). [12] [13] [14] Cloning of the breakpoints of the t(11;18)(q21;q21) showed the fusion of the apoptosis inhibitor-2 (API2) gene and the MALT lymphomaassociated translocation (MALT1) gene at the 11q21 and 18q21 breakpoints, respectively. [15] [16] [17] Immunglobulin gene heavy chain enhancer deregulates the BCL10 gene in the t(1;14)(p22;q32) and the MALT1 gene in the t(14;18)(q32;q21). [18] [19] [20] [21] Recent data have shown that these disparate translocations affect a common signaling mechanism involving BCL10 and MALT1, and thus unify all three under a common pathogenesis, resulting in the activation of the NF-kB pathway. [22] [23] [24] [25] We report on a novel recurrent translocation t(3;14)(p14.1;q32) in MALT lymphoma involving IGH at 14q32 and forkhead box protein P1 (FOXP1) at 3p14.1. The frequency of this translocation was investigated by a two-color fluorescence in situ hybridization (FISH) assay in a large series of MALT lymphomas of different sites.
Materials and methods

Cases
In all, 91 MALT lymphoma cases, eight splenic marginal zone lymphomas, and six nodal marginal zone lymphomas were studied for the presence of t(3;14)(p14;q32) involving IGH and FOXP1. For inclusion in this study, the cases were required to fulfill the histologic and immunohistologic criteria defined for the respective entities in the WHO classification of tumors of hematopoietic and lymphoid tissues. 3, 26 The immunophenotype of the tumor cells, as assessed on paraffin sections, was CD20 þ , cyclin D1À, CD23À, CD5À, bcl-6À, CD10À. Only MALT lymphoma cases without any evidence of large cell transformation were considered to keep the study group as homogenous as possible. Among the total of 91 MALT lymphoma cases, 20 cases each were derived from the stomach, salivary gland, skin, and ocular adnexa; six cases arose in the thyroid and five in the lung. As we expected to find t(3;14)(p14;q32) þ cases most likely among MALT lymphomas negative for any of the three translocations t(11;18)(q21;q21), t(1;14)(p22;q32), and t(14;18)(q32;q21), all of the 91 cases have previously been evaluated for the three translocations and tested negative. The presence of tumor cells was evaluated in each tissue block on hematoxylin-and eosin-stained slides cut before and after the sections used for FISH or reverse transcriptase polymerase chain reaction (RT-PCR) analyses.
Cytogenetic analysis
In the index case, cytogenetic analysis was performed by GAG banding of a freshly obtained MALT lymphoma of the thyroid. 27 The constitutional karyotype of the patient was determined on metaphases from phytohemagglutinin-stimulated lymphocytes. The karyotype was described according to the ISCN (1995). 28 FISH with whole chromosome painting probes for chromosomes 3 and 14 was performed on metaphases. Moreover, IGH dual color break apart rearrangement probes (Vysis, Downer's Grove, IL, USA) were applied. The SpectrumGreen-labeled LSI IGHV probe covers the entire IGH variable region, and the SpectrumOrange-labeled probe lies completely 3 0 to the IGH locus. As a result of this probe design, any translocation with a breakpoint at the J segments or within switch sequences should produce separate orange and green signals.
Long-distance inverse polymerase chain reaction
In the index patient, DNA was isolated from the fresh tumor sample using a high pure PCR template preparation kit (Roche Diagnostics, Mannheim, Germany). The long-distance inverse polymerase chain reaction (LDI-PCR) was performed as described previously. 29 Briefly, high molecular weight DNA was digested with restriction enzymes for 3-4 h at 371C. Restriction digests included BglII, HindIII, PstI, and XbaI. After phenol:chloroform extraction, 0.4 mg of digested DNA was ligated at 151C overnight with T4 DNA ligase. After purification, the ligated DNA was amplified in nested PCR reactions. PCR products were run on agarose gels. Bands were excised from the gels and sequenced using an ABI Prism 310 (PE Applied Biosystems, Foster City, CA, USA). Sequences were compared with the GenBank database using BLAST program (http:// www.ncbi.nlm.nih.gov/BLAST).
FISH analysis
In all cases, except the index patient in which fresh tissue was available, formalin-fixed paraffin-embedded tissue was used. For a reliable interpretation of the hybridization signals, we preferred the analysis of single cell suspensions over thin sections. 20 In all cases, FISH was performed on interphases with two probe sets to detect translocations of the FOXP1 gene. First, a probe (RP11-154H23, RPCI human BAC library 11) spanning the breakpoint of the index patient and containing part of the FOXP1 gene was combined with a probe telomeric to FOXP1 (RP11-215K24). Second, two BAC clones flanking FOXP1 were hybridized (BAC RP11-215K24 telomeric to FOXP1 and BAC RP11-522N9 centromeric to FOXP1). The probes were directly labeled with SpectrumGreen or SpectrumOrange by nick translation (Vysis). In all cases with rearrangement of FOXP1 FISH with a dual color, break apart rearrangement probe for IGH (Vysis) was performed; FISH assays with probes for IGH (Qbiogene, Carlsbad, CA, USA) and FOXP1 (BAC 154H23) were used to confirm the t(3;14)(p14;q32).
All cases were investigated for further MALT lymphomaassociated aberrations t(14;18)(q32;q21), t(1;14)(p22;q32), trisomy 3, and trisomy 18 as described elsewhere. 30 The cutoff value for the diagnosis of each probe set was the mean percentage of cells with a false-positive signal constellation plus 3 standard deviations, as assessed on tissues from 20 reactive lymph nodes.
RT-PCR for API2-MALT1 fusion transcripts
RNA was isolated from archival formalin-fixed, paraffinembedded lymphoma tissues of all cases. Total RNA was extracted from 10 mm sections with a high pure RNA paraffin kit (Roche Diagnostics). First-strand cDNA was synthesized from 1 mg of total RNA with a superscript first-strand synthesis system (Invitrogen) using random hexamers as primers. RT-PCR was performed according to Inagaki et al 31 with one modification: first round RT-PCR products were amplified in a second round separately and not as multiplex nested PCRs in order to discriminate the various fusion signals. Where indicated, PCR products were sequenced.
Real-time quantitative RT-PCR
Frozen tumor samples of 15 MALT lymphomas and nine normal lymph nodes were homogenized in a micro-dismembrator (B Brown Biotech International, Melsungen, Germany) and total RNA was extracted with TRIZOL s reagent (Invitrogen). RNA content was determined by spectrophotometry and the quality assessed using the Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA). Total RNA (10 mg) was reversetranscribed in a final volume of 100 ml, using the high-capacity cDNA Archive Kit (Applied Biosystems). Quantitative RT-PCR (QRT-PCR) analysis was performed on the ABI Prism s 7000 sequence detection system (Applied Biosystems). Gene expression assays (Assay-on-Demand TM ) suitable for this system were carried out according to the manufacturer's instructions (Applied Biosystems). For each data point, duplicate samples were analyzed in parallel. Duplicate assays of serial dilutions of a cDNA standard (Ramos cDNA) were included in each experiment. Transcript levels were normalized for those of TBP and GAPDH to account for variability in the amount of cDNA in each sample and relative expression numbers calculated using the DDCT method.
Results
Cytogenetic analysis and molecular cloning reveals a novel t(3;14)(p14.1;q32) with rearrangement of IGH and FOXP1 in MALT lymphoma
In the index case of a histopathologically typical MALT lymphoma of the thyroid, G-banding analysis revealed a t(3;14)(p14.1;q32) as the primary chromosomal abnormality. [16] .
FISH with whole chromosome painting probes for chromosomes 3 and 14 confirmed the reciprocal translocation ( Figure 1a) . The next FISH experiment was carried out to investigate whether IGH was rearranged on the derivative chromosome 14. The dual color break apart probe for IGH confirmed the rearrangement of the IGH locus showing the SpectrumOrange signal on the der(14) and the SpectrumGreen signal on the der(3) (Figure 1b) .
To characterize the translocation breakpoint on chromosome 3, LDI-PCR was performed. This PCR-based assay allows rapid amplification of all recombination events within the IGH locus. The sequence of a 2 kb LDI-PCR product showed loss of homology with IGH beyond IGHJ6, indicating that this clone contained the translocation breakpoint (Figure 1c) . Comparison of the non-IGH sequence with the human genome sequence showed that it derived from the chromosomal band 3p14.1. The breakpoint was 38 kb upstream of the first 5 0 noncoding exon of FOXP1. The open reading frame of FOXP1 does not appear to be involved with the breakpoint, leaving the coding region of FOXP1 intact. This translocation is therefore similar in structure to other IGH translocations in B-cell lymphomas.
To confirm the breakpoint assessed from LDI-PCR, we performed FISH with BAC clone RP11-154H23, which contains the breakpoint (breakpoint at position 90 971 bp of 193 533 bp complete clone sequence length) and part of the FOXP1 gene. As expected, clone 154H23 was split with partial hybridization to the derivative chromosomes 3 and 14, confirming the breakpoint on chromosome 3 (Figure 1d ).
The t(3;14)(p14.1;q32) involving IGH and FOXP1 is a recurrent translocation in MALT lymphoma Two FISH assays were established to investigate a large series of extranodal MALT lymphomas of different sites and several splenic and nodal marginal zone lymphomas for the presence of translocations of FOXP1. In this screening, only cases negative for t(14;18)(q32;q21), t(11;18)(q21;q21), and t(1;14)(p22;q32) were included.
As listed in Table 1 , nine (10%) of 91 MALT lymphomas harbored a translocation of FOXP1. In all nine cases, FISH (d) A FISH probe (green) covering the breakpoint and part of the FOXP1 gene is combined with an adjacent telomeric probe (orange). A split green signal is seen on der(3) and der (14) , confirming the breakpoint. Table 1 Frequency of t(3;14)(p14.1;q32) involving IGH and FOXP1 relative to lymphoma site
Diagnosis
Cases analyzed (no.) demonstrated that IGH at band 14q32 represented the translocation partner (Figure 2 ). The frequency of the cases positive for the translocation was site dependent. By descending order of frequency, the translocation was detected in MALT lymphomas of the thyroid (three of six), ocular adnexa (four of 20), and skin (two of 20), but not in cases of gastric, pulmonary, and salivary gland origin. Similarly, eight splenic and six nodal marginal zone lymphomas were tested negative. The clinical data of the nine patients with t(3;14)(p14.1;q32) are shown in Table 2 .
Figure 2
Interphase FISH demonstration of t(3;14)(p14.1;q32) on nuclei isolated from paraffin-embedded tissue. (a) Using FISH probes as in Figure 1D , the split green signal indicates a chromosomal breakpoint in the FOXP1 locus. Staging is given according to the Ann Arbor System, as modified by Musshoff and Radaszkiewicz for gastrointestinal lymphomas. Standard staging procedures consisted of computed tomography scanning of thorax and abdomen, gastroscopy with mapping biopsies, endosonography of the upper gastrointestinal tract, enteroclysma, colonoscopy, bone marrow biopsy, imaging of salivary and lacrimal glands by means of magnetic resonance imaging or ultrasound, and ear, nose, and throat investigation. All lesions suggestive of lymphoma involvement were subjected to biopsy. CR, complete remission; PR, partial remission; Lnn, lymph nodes; mos, months; ys, years.
IGH/FOXP1 rearrangement in MALT-lymphoma
MALT lymphomas with t(11;18)(q21;q21) very infrequently display additional genetic aberrations, such as trisomy 3 and/ or trisomy 18, as opposed to t(14;18)(IGH;MALT1) þ and t(1;14)(BCL10;IGH) þ tumors. [32] [33] [34] [35] To investigate whether this is also the case in MALT lymphomas positive for t(3;14)(p14.1;q32), the nine lymphomas harboring this translocation were screened by FISH using centromere-specific probes for chromosomes 3 and 18. Five lymphomas exhibited trisomy 3 and one case tetrasomy 18. Therefore, together with the cytogenetic findings of a trisomy 22 in the index patient, t(3;14)(p14.1;q32) þ MALT lymphomas showed additional chromosomal aberrations in seven of nine cases.
T(3;14)(p14.1;q32) and translocations of MALT1 and BCL10 are mutually exclusive
As described above, the t(3;14)(p14.1;q32) þ cases were negative for t(14;18)(q32;q21), t(11;18)(q21;q21), and t(1;14)(p22;q32).
In order to exclude a hidden t(3;14)(p14.1;q32) among MALT lymphomas with known translocations, further 14 t(11;18)(q21;q21) þ , 20 t(14;18)(q32;q21) þ , and four t(1;14)(p22;q32) þ MALT lymphomas were tested negative for t(3;14)(p14.1;q32), indicating that the t(3;14)(p14.1;q32) and the other translocations are mutually exclusive (data not shown).
T(3;14)(p14.1;q32) leads to deregulation of FOXP1 To determine whether FOXP1 was deregulated as a consequence of the juxtaposition to IGH, QRT-PCR for FOXP1 was performed in a series of 15 MALT lymphomas comprising six cases with t(11;18)(q21;q21), three cases with t(14;18)(q32;q21) and two t(3;14)(p14.1;q32) þ MALT lymphomas. The remaining four cases were translocation negative. Two of the 15 cases harbored trisomy 3. Highest levels of FOXP1 expression were detected in both cases with t(3;14)(p14.1;q32) and the t(14;18)(q32;q21) þ case with trisomy 3 (Figure 3 ). Among the group of translocation-negative MALT lymphomas, the case with trisomy 3 showed the highest FOXP1 expression. Interestingly, in a t(11;18)(q21;q21) þ case, FOXP1 expression was at a similar high level. The high expression of FOXP1 in this patient is unclear, as trisomy 3 and amplification of FOXP1 were excluded. Although the number of investigated cases is low, QRT-RT demonstrated an overexpression of FOXP1 in the cases with t(3;14)(p14.1;q32) or trisomy 3.
Discussion
In the present study, we have identified a novel rearrangement of a member of the winged helix family. FOXP1 at 3p14 was juxtaposed to the IGH locus at 14q32 in a MALT lymphoma of the thyroid. By screening a series of 91 MALT lymphomas, all of which were negative for the known three translocations, t(3;14)(p14;q32) was detected in nine cases (10%). These nine t(3;14)(p14;q32) þ MALT lymphomas showed a striking clustering at certain anatomic sites, that is, the thyroid with three of six cases positive, the ocular adnexa with four of 20, and the skin with two of 20 lymphomas carrying this aberration. By contrast, all MALT lymphomas arising in the stomach, salivary gland, and lung were tested negative. A nonrandom anatomic distribution has also been demonstrated for the other MALT lymphomaassociated translocations, that is, t(1;14)(p22;q32) and t(11;18)(q21;q21) in gastrointestinal and pulmonary lesions, and t(14;18)(q32;q21) in tumors of the liver, ocular adnexa, skin, and salivary gland. 30 Additionally, our study revealed that the t(3;14)(p14;q32) and the other three MALT lymphoma-associated translocations occur mutually exclusive. Aneuploidy, most frequently trisomy 3, was shown in seven of the nine t(3;14)(p14;q32) þ cases, suggesting that the majority of t(3;14)(p14;q32) þ MALT lymphomas harbor secondary genetic aberrations. This is in contrast to MALT lymphomas with t(11;18)(q21;q21), which usually do not have additional genetic aberrations. 32, 33 FOXP1 is a member of the FOXP subfamily (FOXP1-4) of transcription factors, characterized by a common DNA binding forkhead domain. 36 The forkhead domain was defined by the homology of the DNA-binding domains between HNF-3 and Drosophila forkhead genes. [37] [38] [39] Proteins with forkhead domains are grouped into the winged helix family. In normal tissues, members of this family of transcription factors take part in a wide range of biological functions, including the control of cellular differentiation and proliferation, pattern formation, and signal transduction. 40 Moreover, genes belonging to the winged helix family have been shown to be rearranged in human malignancies. In acute leukemia, AFX and AF6q21 have been identified to be fused to MLL. 41, 42 In alveolar rhabdomyosarcoma, FKHR fuses to PAX3 and PAX7. 43, 44 FOXP1 has been shown to be expressed in normal and neoplastic B cells. In normal tonsil, FOXP1 protein is predominantly found in mantle zone B cells, whereas only a variable proportion of the germinal center cells express this protein. 36 In a subset of diffuse large B-cell lymphomas (DLBCLs), FOXP1 is highly expressed. Two recent studies investigated FOXP1 expression in prognostically significant subgroups of DLBCLs. In one study, FOXP1 was expressed in 48% of the germinal center B-cell (GCB) like subgroup and in 71% of the non-GCB group, but did not predict clinical outcome. 45 In the other study, strong nuclear FOXP1 expression correlated with poor prognosis in BCL2-positive, t(14;18)(IGH;BCL2)-negative non-GC-DLBCLs. 46 Despite the ambiguous significance of FOXP1 expression for the clinical outcome, the strong expression of FOXP1 in a subset of DLBCLs Figure 3 Analysis of FOXP1 expression by real-time quantitative RT-PCR. Highest levels of FOXP1 expression are detected in the two cases with t(3;14)(p14.1;q32) and trisomy 3 and a case with t(11;18)(q21;q21).
IGH/FOXP1 rearrangement in MALT-lymphoma B Streubel et al argues for a possible role in the pathogenesis of this group of aggressive B-cell lymphomas. As a consequence of the t(3;14)(p14;q32), FOXP1 is deregulated through its juxtaposition to IGH. QRT-PCR demonstrated upregulation in the two t(3;14) þ MALT lymphomas examined. In two further cases with trisomy 3, deregulation of FOXP1 was also demonstrated. This finding is interesting as gains of chromosomes 3 are one of the most common aberrations in MALT lymphoma, but infrequent in other B-cell malignancies. 30, 47 Therefore, FOXP1 may play a role in the pathogenesis in a proportion of MALT lymphomas. The mechanisms by which FOXP1 contributes to the tumorigenesis are unclear and speculative. FOXP1 has multiple transcriptional domains with complex regulatory mechanisms. 48 Sequence analysis of the normal FOXP1 protein revealed -besides the forkhead domain -a nucleic acid-binding zinc-finger domain and several potential transactivation domains (acidic, glutamine-, proline-, serine-, and threonine-rich domains). 38 Similar domains have been shown to interact with the basal transcription machinery in a number of transcription factors. [49] [50] [51] Although our study does not provide insight into oncogenic pathways involved with t(3;14)(p14.1;q32), our findings suggest a hitherto unrecognized role of FOXP1 in a subset of MALT lymphomas. Further studies will show if FOXP1 is -like the other three known translocations in MALT lymphoma -involved in activating the NF-kB pathway.
